ENCBS395GPZ / in vitro differentiated cells

Summary

Status
released
Term name
cardiac muscle cell
Term ID
CL:0000746
Summary
Homo sapiens female embryo cardiac muscle in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days
Description
H7 hESC to cardiomyocyte, endothelial and smooth muscle cell differentiation treatment for 14 days
Originated from biosample
ENCBS336AYE

Attribution

ENCODE2 project
Lab
John Stamatoyannopoulos, UW
Award PI
John Stamatoyannopoulos, UW
Submitted by
Aditi Narayanan
Source
Unknown Source
Project
ENCODE
Aliases
john-stamatoyannopoulos:31hao8

Treatment details

Treatment
5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 14 days
Type
protein
Treatment
10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 14 days
Type
protein
Treatment
6 ng/mL Activin A (CHEBI:81351) for 14 days
Type
chemical

Donor information

Status
released
Accession
ENCDO221AAA
Aliases
encode:donor of H7
Species
Homo sapiens
Life stage
embryonic
Sex
female
External resources

Documents

differentiation protocol
Description: H7 Mesoderm 14-day Differentiation Protocol
Submitted by
John Stamatoyannopoulos
Lab
John Stamatoyannopoulos, UW